other material
confidence high
sentiment positive
materiality 0.75
Arvinas clears HSR for $150M upfront from Novartis; $1.01B milestones remain
ARVINAS, INC.
- HSR waiting period expired May 28, 2024; all closing conditions satisfied for the transaction.
- Novartis to pay Arvinas a one-time upfront payment of $150 million.
- Arvinas eligible for up to $1.01 billion in contingent milestone payments for ARV-766.
- Also eligible for tiered royalties based on worldwide net sales of ARV-766.